Tools · Private company · San Diego, CA, US
Big Eye Diagnostics, Inc.
Track this companyFree. Adds Big Eye Diagnostics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards7
- Ultrasensitive, High-Specificity Rapid Test to Support the End-Game of the Global Program to Eliminate Lymphatic FilariasisFiscal year 2025 · $842.4KNIH RePORTER 5R44AI170131-03 · fetched Nov 12, 2026
- Supporting WHO Lymphatic Filariasis Elimination Programs: Progressing a Highly Sensitive and Specific Rapid Diagnostic Test for Brugia Species Infection to Commercialization ReadinessFiscal year 2025 · $396.5KNIH RePORTER 5R44AI184015-02 · fetched Nov 12, 2026
- NOVEL DIAGNOSTIC BIOMARKERS DISCOVERY AND VALIDATION FOR SELECT NEGLECTED TROPICAL DISEASES Fiscal year 2025 · $300KNIH RePORTER 75N93025C00005-0-9999-1 · fetched Nov 12, 2026
- Supporting WHO Lymphatic Filariasis Elimination Programs: Progressing a Highly Sensitive and Specific Rapid Diagnostic Test for Brugia Species Infection to Commercialization ReadinessFiscal year 2024 · $797.2KNIH RePORTER 1R44AI184015-01 · fetched Nov 12, 2026
- Ultrasensitive, High-Specificity Rapid Test to Support the End-Game of the Global Program to Eliminate Lymphatic FilariasisFiscal year 2024 · $852.7KNIH RePORTER 4R44AI170131-02 · fetched Nov 12, 2026
- SUPPORTING WHO ONCHOCERCIASIS ELIMINATION PROGRAMS: PROGRESSING A HIGHLY SENSITIVE AND ULTRA-SPECIFIC RAPID DIAGNOSTIC TEST TO COMMERCIALIZATION READINESSFiscal year 2024 · $908.3KNIH RePORTER 5R44AI174495-02 · fetched Nov 12, 2026
- An Easy-to-Use, Low-Cost Triplex RDT for the Simultaneous Diagnosis of HBV, HCV, AND HIV Infection, Compatible with Field Use in LMICS and At-Home Use in the USFiscal year 2024 · $299.7KNIH RePORTER 75N93024C00025-0-9999-1 · fetched Nov 12, 2026